07.16.26 -- What Biopharma Often Overlooks In A Scheduled Shutdown

Real-time cell health monitoring reveals how drug dose and timing impact apoptosis, necrosis, and viability. Explore how automated workflows help pinpoint mechanistic toxicity windows.

OEE provides a high-level view of equipment performance, but it doesn’t explain the root causes. See why manufacturers need deeper insight to turn utilization metrics into meaningful improvements.

Review the formulation and manufacturing considerations for amorphous solid dispersions (ASDs), with a focus on hot melt extrusion (HME) as a scalable and cost-effective technology option.

Scaling complex chemical processes requires early risk identification, integrated safety and analytical expertise, and efficient tech transfer.

Biopharma success depends on agility. Move efficiently from discovery to delivery by co-locating drug substance and drug product operations, reducing transfer risks and accelerating your timeline

Here, we provide systematic methods to increase return on investment. Discover the seven primary investment recovery channels.

Continuous monitoring is transforming manufacturing. With advanced analytics and sensor technologies, teams can detect issues early and optimize processes in real time for greater efficiency.

Native SEC‑MALS offers a calibration‑free way to accurately characterize peptide oligomers, helping scientists distinguish true higher‑order structures while avoiding bias.

Stay ahead of the evolving UK regulatory landscape and leverage upcoming reforms to accelerate patient access, drive innovation, and strengthen your position in the medicines development market.

Gain insight into a coordinated, around-the-clock approach that demonstrates how packaging efficiency can keep pace with urgent pharmaceutical launches and tight commercialization timelines.

Combining Functional Design of Experiments (Functional DOE) with traditional DOE methods enhances process optimization by capturing dynamic, time-based variations in cell culture systems.

A solvent‑free, fusion‑based approach streamlines amorphous solid dispersion development, enabling rapid early screening, improved performance, and sustainable manufacturing.

Examine the optimization of the manufacturing process of a pharmaceutical intermediate, as well as how yield can be improved substantially via suitable reaction engineering.

Standardizing governance and data foundations is critical for scaling multi-site networks without increasing risk. Learn to leverage reusable validation and harmonized workflows for audit readiness.

Delve into how life sciences innovators use industrial data fabrics to eliminate manual tech transfer errors, bridge departmental silos, and accelerate time-to-market.

Find out how vision inspection software helps injectable drug manufacturers meet USP <790> standards by improving defect detection, ensuring data integrity, and eliminating paper-based risks.